NTRBW
HealthcareNutriband Inc - Warrants (30/09/2026)
Live · NASDAQ · May 9, Close
What's Moving NTRBW Today?
No stock-specific AI insight has been generated for NTRBW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.53
Fundamentals
Trading
NTRBW News
20 articles- Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel PodcastYahoo Finance·Apr 22, 2026
- Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl PatchYahoo Finance·Mar 30, 2026
- Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa RicaYahoo Finance·Mar 18, 2026
- REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl PatchYahoo Finance·Oct 28, 2025
- Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl PatchYahoo Finance·Oct 28, 2025
- Nutriband Co-Founder Gareth Sheridan Returns as CEOYahoo Finance·Oct 27, 2025
- Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl PatchYahoo Finance·Oct 10, 2025
- Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent TechnologyYahoo Finance·Oct 8, 2025
- Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity ConferenceYahoo Finance·Oct 8, 2025
- 11 Company Presentations Today at The MicroCap Rodeo ConferenceYahoo Finance·Sep 25, 2025
- Nutriband Inc. to Present at the MicroCap Rodeo ConferenceYahoo Finance·Sep 24, 2025
- Nutriband Second Quarter 2026 Earnings: Misses ExpectationsYahoo Finance·Sep 11, 2025
- Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA FentanylYahoo Finance·Sep 10, 2025
- Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue EstimatesYahoo Finance·Sep 9, 2025
- Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000Yahoo Finance·Sep 3, 2025
- Nutriband's (NASDAQ:NTRB) investors will be pleased with their favorable 37% return over the last three yearsYahoo Finance·Aug 22, 2025
- Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live streamYahoo Finance·Aug 20, 2025
- Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live streamYahoo Finance·Aug 19, 2025
- Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025Yahoo Finance·Aug 18, 2025
- Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential ElectionYahoo Finance·Aug 11, 2025
All 20 articles loaded
Price Data
52-Week Range
$1.53
Fundamentals
Trading
About Nutriband Inc - Warrants (30/09/2026)
Nutriband Inc. Warrant (NTRBW) offers a unique investment opportunity tied to Nutriband Inc., a forward-thinking biotech company known for its revolutionary transdermal drug delivery systems. The company focuses on improving patient outcomes in pain management and addiction treatment, characterized by an innovative therapeutic pipeline designed to address significant healthcare challenges. With its proprietary technologies and a strategic vision, Nutriband is poised to leverage growth opportunities in the dynamic pharmaceutical landscape, making it an attractive prospect for institutional investors targeting the biotech sector.